HYOJIN LEE: Open Payments
NPI 1437615978 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$214 in 8 payments from 5 companies in 2025. Trend: 2023 $323 · 2024 $365 · 2025 $214
Food & beverage: $214
| Company | Payments | Amount |
|---|---|---|
| La Jolla Pharmaceutical Company | 3 | $82 |
| ABBVIE INC. | 2 | $56 |
| Merck Sharp & Dohme LLC | 1 | $34 |
| Medtronic, Inc. | 1 | $25 |
| Intercept Pharmaceuticals, Inc. | 1 | $17 |
Products named: GIAPREZA, ZERBAXA, SIGNIA, AVYCAZ, OCALIVA.
Industry payments across TX — which companies pay providers there.
